调强放疗模式下诱导化疗联合同期放化疗对鼻咽癌患者的临床疗效分析

详细信息    查看全文 | 推荐本文 |

英文篇名：Analysis of the Effect of Induced Chemotherapy Combined with Concurrent Chemoradiotherapy on the Clinical Efficacy of Nasopharyngeal Carcinoma Patients under the Mode of Intensity Modulated Radiotherapy 作者：陈瑞仲 ; 高文蓝 ; 梁伟 ; 邹元梅 ; 叶碧翠 ; 朱锦贤 英文作者：CHEN Ruizhong;GAO Wenlan;LIANG Wei;Red Cross Hospital of Wuzhou City; 关键词：鼻咽癌 ; 调强放疗 ; 诱导化疗 ; 同期放化疗 英文关键词：Nasopharyngeal carcinoma;;Intensity modulated radiotherapy;;Induction chemotherapy;;Concurrent chemoradiation 中文刊名：SYAZ 英文刊名：The Practical Journal of Cancer 机构：广西梧州市红十字会医院;广西梧州市人民医院; 出版日期：2019-03-25 出版单位：实用癌症杂志 年：2019 期：v.34;No.204 语种：中文; 页：SYAZ201903031 页数：4 CN：03 ISSN：36-1101/R 分类号：109-112

摘要

目的探讨调强放疗(IMRT)模式下诱导化疗联合同期放化疗对鼻咽癌(NPC)患者的临床疗效。方法回顾性分析NPC初诊患者133例的临床资料,其中进行诱导化疗以后再进行同期放化疗者68例,为观察组;进行诱导化疗以后进行放疗者65例,为对照组。2组均进行根治性剂量的IMRT。患者在放疗前都进行诱导化疗,诱导化疗均应用双药结合TP方案(铂类结合紫杉醇)和同期化疗为单药铂类。观察2组患者近期治疗效果、生存状况及不良反应情况。结果 2组患者颈部转移灶与鼻咽原发灶治疗有效率均为100. 0%,对比差异无统计学意义(P> 0. 05)。2组患者1年、2年OS及PFS对比差异无统计学意义(P> 0. 05)。观察组3～4级白细胞下降、口咽黏膜炎发生率高于对照组,差异有统计学意义(P <0. 05)。结论同期放化疗并不能为IMRT治疗模式下NPC患者带来更多益处,反而会增加患者不良反应发生率。
        Objective To investigate the clinical efficacy of induction chemotherapy combined with concurrent chemoradiotherapy in patients with nasopharyngeal carcinoma( NPC) under IMRT mode. Methods The clinical data of 133 newly diagnosed NPC patients were retrospectively analyzed. Sixty-eight patients who underwent concurrent chemoradiation after induction chemotherapy were observation groups. Sixty-five patients who underwent radiotherapy after induction chemotherapy were control subjects. Radical dose of IMRT was performed in both groups. All patients received induction chemotherapy before radiotherapy.Induction chemotherapy was performed using dual drugs combined with TP regimen( platinum combined with paclitaxel) and concurrent chemotherapy as single agent platinum. Observe the short-term treatment effect,survival condition and adverse reactions of the two groups of patients. Results The effective rates of cervical metastases and nasopharyngeal primary lesions in both groups were 100. 0%. There were no PD and SD patients,and the difference was not statistically significant( P > 0. 05). There was no significant difference in OS and PFS between the two groups at 1 year and 2 years( P > 0. 05). The incidence of white blood cell decline and oropharyngeal mucositis at the 3 rd to 4 th level in the observation group was higher than that in the control group,and the difference was statistically significant( P < 0. 05). Conclusion Concurrent radiotherapy and chemotherapy can not bring more benefits to NPC patients in the IMRT treatment mode,but will increase the incidence of adverse reactions in patients.

引文

[1]丘文泽,黄培钰,施君理,等.调强放疗结合诱导化疗或同期加辅助化疗治疗局部晚期鼻咽癌的疗效比较〔J〕.中国肿瘤临床,2015,42(4):231-235.
    [2]夏海群,华贻军,彭醒思,等.诱导化疗加放疗与同期放化疗治疗局部晚期鼻咽癌的疗效比较〔J〕.中国肿瘤,2016,25(5):386-390.
    [3] Cao CN,Luo JW,Gao L,et al. Update report of T4 classification nasopharyngeal carcinoma after intensity-modulated radiotherapy:An analysis of survival and treatment toxicities〔J〕. Oral Oncology,2015,51(2):190-194.
    [4]李梅,杨智宁,蔡庆鑫,等.调强放疗联合诱导化疗对比同期化疗治疗局部晚期鼻咽癌前瞻性研究的初期报告〔J〕.肿瘤研究与临床,2017,29(4):245-250.
    [5]张晓军,楚建军,王明智,等.调强放疗模式下局部晚期鼻咽癌诱导化疗后同期化疗与单纯放疗疗效比较〔J〕.现代肿瘤医学,2016,24(23):3720-3724.
    [6] Zhang L,Shan GP,Li P,et al. The role of concurrent chemotherapy to intensity-modulated radiotherapy(IMRT)after neoadjuvant docetaxel and cisplatin treatment in locoregionally advanced nasopharyngeal carcinoma〔J〕. Medical Oncology,2015,32(3):41-45.
    [7]朱锦贤,刘园源,梁锦辉,等.多西他赛联合顺铂诱导化疗后三维适形调强放疗同步化疗对局部晚期鼻咽癌的疗效分析〔J〕.实用癌症杂志,2016,31(8):1357-1360.
    [8]谢鹏,姜力,夏冬梅,等.诱导化疗+IMRT同期化疗与IMRT同期化疗治疗局部中晚期鼻咽癌的远期疗效比较〔J〕.肿瘤防治研究,2016,43(11):969-973.
    [9]杨熙,徐子海,许春本,等. 78例鼻咽癌调强放疗疗效和预后因素分析〔J〕.现代肿瘤医学,2016,24(12):1887-1891.
    [10] Yi J,Huang X,Li G,et al. Intensity-modulated radiotherapy with simultaneous integrated boost for locoregionally advanced nasopharyngeal carcinoma〔J〕. Radiation Oncology,2014,9(1):56-59.
    [11] Wee CW,Keam B,Heo DS,et al. Locoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiotherapy plus concurrent weekly cisplatin with or without neoadjuvant chemotherapy〔J〕. Radiation Oncology Journal,2015,33(2):98-103.
    [12]李卓玲,金风,吴伟莉,等.诱导化疗加同步放化疗治疗鼻咽癌的临床观察〔J〕.现代肿瘤医学,2015,23(6):774-778.
    [13]毛振华,金风,吴伟莉,等. TPF诱导化疗序贯同步放化疗治疗初治远处转移鼻咽癌的临床分析〔J〕.现代肿瘤医学,2015,5(7):916-921.
    [14]欧瑶,罗居东.诱导化疗加IMRT同期化疗治疗96例局部晚期鼻咽癌远期疗效〔J〕.实用医学杂志,2017,33(2):185-188.
    [15] Lin S,Lu JJ,Han L,et al. Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma:experience of 370 consecutive cases〔J〕. Bmc Cancer,2010,10(1):39-43.